AMANTA — Amanta Healthcare Income Statement
0.000.00%
- IN₹5.48bn
- IN₹7.49bn
- IN₹2.75bn
- 91
- 28
- 61
- 67
Annual income statement for Amanta Healthcare, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2010 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | PROSPECTUS | PROSPECTUS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Other Revenue | |||||
Total Revenue | 935 | 2,254 | 2,591 | 2,803 | 2,747 |
Cost of Revenue | |||||
Gross Profit | 211 | 1,453 | 1,536 | 1,707 | 1,768 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 784 | 1,206 | 2,237 | 2,420 | 2,332 |
Operating Profit | 151 | 1,049 | 354 | 383 | 416 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 50 | 618 | 26.9 | 53.9 | 147 |
Provision for Income Taxes | |||||
Net Income After Taxes | 25.8 | 539 | -21.1 | 36.3 | 105 |
Net Income Before Extraordinary Items | |||||
Net Income | 25.8 | 539 | -21.1 | 36.3 | 105 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 27.6 | 539 | -21.1 | 36.3 | 105 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.794 | 2.41 | -0.466 | 0.833 | 2.72 |
Dividends per Share |